Exchange: Other OTC Sector: Healthcare Industry: Biotechnology
0.00% $0.602
/ 19 apr 2024 @ 11:36
FUNDAMENTALS | |
---|---|
MarketCap: | 4.35 mill |
EPS: | -1.240 |
P/E: | -0.490 |
Earnings Date: | Dec 31, 2017 |
SharesOutstanding: | 7.23 mill |
Avg Daily Volume: | 0.0001 mill |
RATING 2024-04-10 |
---|
C |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Strong Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.490 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -0.490 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
$-0.127 (-121.02%) $-0.729 |
Date: 2024-04-25 |
Expected Trading Range (DAY) |
---|
$ 0.557 - 0.647 ( +/- 7.47%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2019-01-31 | Mckinney Daniel S | Sell | 25 000 000 | Common Stock |
2018-12-18 | Mckinney Daniel S | Buy | 900 | Common Stock |
2018-11-27 | Mckinney Daniel S | Buy | 200 | Common Stock |
2018-11-17 | Mckinney Daniel S | Buy | 300 | Common Stock |
2018-11-08 | Mckinney Daniel S | Buy | 200 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 7 transactions |
Buy: 25 001 900 | Sell: 25 000 000 |